Left Atrial Appendage Occlusion Registry (LAAO Registry)
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- American College of Cardiology
- Study ID
- NCT02699957
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Left Atrial Appendage Occlusion — PROCEDUREPatients undergoing percutaneous/epicardial intervention for left atrial appendage occlusion.
Study Details
The Left Atrial Appendage Occlusion Registry (LAAO Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous and epicardial based left atrial appendage occlusion procedures to reduce the risk of stroke. Patient-level data will be submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). The primary aims of the LAAO Registry are to optimize the outcomes and management of patients through the implementation of evidence-based guideline recommendations in clinical practice, facilitate efforts to improve the quality and safety for patients undergoing percutaneous and epicardial based left atrial appendage procedures, investigate novel quality improvement methods and provide risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary purpose of the LAAO Registry is to serve as a rich source of clinical data to support assessments of short- and long-term safety, comparative and cost effectiveness research, and as a scalable data infrastructure for post market studies.
Key Dates
- Start date
- Dec 31, 2015
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2029
Study Design
- Enrollment
- 3,000 participants (estimated)
Arms
- Arm: Atrial FibrillationThose patients with the condition of atrial fibrillation.
Primary Outcome Measure
Proportion of patients with a major complication [ Time Frame: Assessed in hospital for any occurence from the start of procedure date and time until discharge date and time, assessed up to 24 months. Reported quarterly. ]
Central Contacts
- Mark Fox, CHC, CHPC202-375-6305
- Christina Koutras, RN, BSN202-375-6387
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| American College of Cardiology/National Cardiovascular Data Registry (NCDR) | Washington D.C. | District of Columbia | 20037 |
Find similar trials in Washington D.C., DC
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Tracking Results of Ablations to Combat AF Registry Generation 2Recruiting · AtriCure, Inc. · Huntsville, Alabama
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama